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Purpose: Two consanguineous Pakistani families with autosomal recessive primary congenital glaucoma were recruited
to identify the disease locus.
Methods: Ophthalmic examinations including slit lamp biomicroscopy and applanation tonometry were employed to
classify the phenotype. Blood samples were collected and genomic DNA was extracted. A genome wide scan was
performed on both families with 382 polymorphic microsatellite markers. Two point LOD scores were calculated, and
haplotypes were constructed to define the disease interval.
Results: Clinical records and ophthalmic examinations suggest that affected individuals in families PKGL005 and
PKGL025 have primary congenital glaucoma. Maximum two-point LOD scores of 5.88 with D14S61 at θ=0 and 6.19
with D14S43 at θ=0 were obtained for families PKGL005 and PKGL025, respectively. Haplotype analysis defined the
disease locus as spanning a 6.56 cM (~4.2 Mb) genetic interval flanked by D14S289 proximally and D14S85 distally.
Conclusions: Linkage analysis localizes autosomal recessive primary congenital glaucoma to chromosome 14q24.2–24.3
in consanguineous Pakistani families.
Glaucoma is the second leading cause of vision loss, and
approximately  15%  of  blindness  worldwide  result  from
glaucoma  [1].  It  is  a  group  of  poorly  understood
neurodegenerative disorders that are usually associated with
elevated intraocular pressure [2]. Glaucoma is clinically and
genetically heterogeneous with several different forms, each
with  diverse  causes  and  severities.  Clinically,  it  is
characterized by slow but progressive degeneration of retinal
ganglion cells and their axons, leading to deterioration of the
visual field and to optic nerve atrophy.
Although rare, primary congenital glaucoma (PCG) is the
most common form of glaucoma in infants with an overall
occurrence of 1 in 10,000 births [3]. It is prevalent in countries
where consanguinity is common with incidence as high as 1
in 1,250 births in the Slovak population, 1 in 2,500 births in
Saudi Arabia, and 1 in 3,300 births in the state of Andhra
Pradesh in India [4,5]. PCG is an inherited ocular congenital
anomaly of the trabecular meshwork and anterior chamber
angle [6-9]. This leads to the obstruction of aqueous outflow
and increased intraocular pressure (IOP) resulting in optic
nerve damage leading to childhood blindness. The disease
manifests  in  the  neonatal  or  early  infantile  period  with
symptoms  of  photophobia,  epiphora,  signs  of  globe
enlargement, edema, opacification of the cornea, and breaks
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in Descemet's membrane. The mode of inheritance is largely
autosomal recessive with variable penetrance, but rare cases
of pseudo dominance are also seen in families with multiple
consanguinity [10-13]. To date, three genetic loci have been
reported for autosomal recessive PCG, GLC3A (2p21; OMIM
231300),  GLC3B  (1p36;  OMIM  600975),  and  GLC3C
(14q24.3), with pathogenic mutations only reported in the
human cytochrome P450 gene (CYP1B1; OMIM 601771)
[14,15]. It is significant to note that CYP1B1 mutations have
also been reported in patients with early onset of primary
open-angle  glaucoma.  Additionally,  autosomal  dominant
forms  of  PCG  have  been  reported,  and  MYOC,  a  gene
associated with primary open-angle glaucoma, is reported to
play a possible role in the pathogenesis [16,17].
The current study is aimed to explore the genetic basis of
PCG in the Pakistani population. A genome wide linkage
analysis was performed, which showed segregation of PCG
in  two  consanguineous  Pakistani  families.  Microsatellite
markers on chromosome 14q24.2–24.3 cosegregated with the
disease phenotype and defined the disease locus as spanning
a 6.56 cM (~4.2 Mb) genetic interval flanked by D14S289
proximally and D14S85 distally.
METHODS
Thirteen consanguineous Pakistani families with PCG were
recruited to participate in this study to understand the genetic
aspects of glaucoma at the Centre of Excellence in Molecular
Biology  (Lahore,  Pakistan).  Institutional  Review  Board
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1659approval  was  obtained  for  this  study  from  the  Centre  of
Excellence in Molecular Biology (CEMB). The participating
subjects gave informed consent consistent with the tenets of
the Declaration of Helsinki. Both families described in this
study are from the Punjab province of Pakistan.
A detailed medical history was obtained by interviewing
family  members.  All  of  the  ophthalmic  examinations
including slit lamp biomicroscopy and applanation tonometry
were completed at the Layton Rahmatullah Benevolent Trust
(LRBT) hospital (Lahore, Pakistan). Diagnosis of PCG was
based on established criteria that include measurement of IOP,
measurement of corneal diameters, and observation of optic
nerve head where possible as well as symptoms of corneal
edema including photophobia, buphthalmos, cloudy cornea,
and excessive tearing. Patients with elevated IOP associated
with other systemic or ocular abnormalities were excluded.
Blood samples were collected from affected and unaffected
family  members.  DNA  was  extracted  by  a  non-organic
method as described by Grimberg et al. [18].
Genotype analysis: A genome wide scan was performed
with 382 highly polymorphic fluorescent markers from the
ABI  PRISM  Linkage  Mapping  Set  MD-10  (Applied
Biosystems, Foster City, CA) having an average spacing of
10 cM. Multiplex polymerase chain reactions (PCRs) were
performed in a 5 μl mixture containing 40 ng genomic DNA,
various combinations of 10 μM dye labeled primer pairs,
0.5 μl 10X GeneAmp PCR Buffer II, 0.5 μl 10mM Gene Amp
dNTP mix, 2.5 mM MgCl2, and 0.2 U of Taq DNA polymerase
(AmpliTaq  Gold  Enzyme;  Applied  Biosystems).
Amplification was performed in a GeneAmp PCR System
9700  (Applied  Biosystems).  Initial  denaturation  was
performed for 5 min at 95 °C followed by 10 cycles for 15 s
at 94 °C, for 15 s at 55 °C, and for 30 s at 72 °C, and then 20
cycles for 15 s at 89 °C, for 15 s at 55 °C, and for 30 s at 72 °C.
The  final  extension  was  performed  for  10  min  at  72  °C
followed by a final hold at 4 °C. PCR products from each DNA
sample  were  pooled  and  mixed  with  a  loading  cocktail
containing HD-400 size standards (PE Applied Biosystems).
The resulting PCR products were separated in an ABI 3100
DNA  Analyzer  and  analyzed  by  using  the  GeneMapper
software package (Applied Biosystems).
Linkage  analysis:  Two  point  linkage  analysis  were
performed using the FASTLINK version of MLINK from the
LINKAGE Program Package (provided in the public domain
by the Human Genome Mapping Project Resources Centre,
Cambridge,  UK)  [19,20].  Maximum  LOD  scores  were
calculated  using  ILINK.  Autosomal  recessive  PCG  was
analyzed  as  a  fully  penetrant  trait  with  an  affected  allele
frequency of 0.001. The marker order and distances between
the markers were obtained from the Marshfield database. For
the initial genome scan, equal allele frequencies were assumed
while for fine mapping, allele frequencies were estimated
from  100  unrelated  and  unaffected  individuals  from  the
Punjab province of Pakistan.
Mutation screening: Individual exons were amplified by
PCR  using  primer  pairs  designed  by  using  the  primer3
program (primer sequences and annealing temperatures are
available upon request). Amplifications were performed in 25
μl reactions containing 50 ng of genomic DNA, 2.5 μl 10X
GeneAmp PCR Buffer II, 8 pmoles of each primer, 2.5 mM
dNTP, 2.5 mM MgCl2, and 0.2 U Taq DNA polymerase.
Amplification was performed in a GeneAmp PCR System
9700 (Applied Biosystems). PCR amplification consisted of
a denaturation step at 96 °C for 5 min followed by 40 cycles,
each cycle starting at 96 °C for 45 s followed by 57 °C for 45
s and 72 °C for 1 min. PCR products were analyzed on 2%
agarose gel and purified by ethanol precipitation. The PCR
primers for each exon were used for bidirectional sequencing
using  Big  Dye  Terminator  Ready  reaction  mix  (Applied
Biosystems)  according  to  manufacturer  instructions.
Sequencing products were precipitated and resuspended in
10  μl  of  formamide  and  denatured  at  95  °C  for  5  min.
Sequencing  was  performed  on  an  ABI  PRISM  3100
Automated  sequencer  (Applied  Biosystems).  Sequencing
results  were  assembled  by  the  ABI  PRISM  sequencing
analysis software version 3.7 and analyzed using Chromas
software (version 1.45).
TABLE 1. CLINICAL FEATURES OF AFFECTED INDIVIDUALS OF FAMILIES PKGL005 AND PKGL025.
 Family
number
Individual
      ID Gender
Age of
 onset
Age at
time of
study
Maximum
     IOP
(OD/OS)
C/D ratio
(OD/OS)
Visual
acuity
(OD/OS) Other changes
PKGL005 11 M 3 years 8 years 32/20* 0.8/NV CF/CF Megalocornea
PKGL005 41 M 3 years 6 years 38/30 1.0/0.3 CF/CF Megalocornea
PKGL025 15 F By birth 4 years 20*/24* 0.3/0.3 CF/CF Buphthalmos
PKGL025 28 M By birth 8 months 25/26 NA CF/CF Buphthalmos
PKGL025 25 F By birth 5 years 12*/16* 0.9/0.9 CF/CF Megalocornea,
cornea haze
PKGL025 24 F By birth 15 years NA/38 NV/1.0 NPL/NPL Buphthalmos
An asterisk indicates that IOP is controlled by medical or surgical treatment. IOP, intraocular pressure; OD, right eye; OS, left
eye; PL, perception of light; NPL, no perception of light; HM, hand motion; NA, not available; NV, no view because of eyeball
atrophy or corneal opacity; CF, counting fingers.
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The two families reported here, PKGL005 and PKGL025, are
from  the  Punjab  province  of  Pakistan.  Ophthalmic
examinations and medical history for both families concluded
that a total of 11 affected individuals in both families have
primary congenital glaucoma (PCG). The symptoms of PCG
in affected individuals of PKGL005 appeared in the first three
years of life. Visual acuity was confined to light perception
and/or counting fingers. The cup to disc ratios of affected
individuals 11 and 41 were 0.8 (OD) and 1.0/0.3 (OD/OS),
and the recorded IOPs for individuals 11 and 41 were 32/20
mm Hg (OD/OS) and 38/30 mm Hg (OD/OS), respectively
(Table 1). On the other hand, symptoms of PCG in PKGL025
were either present at birth or appeared in the first six weeks
of life. Visual acuity was reduced to counting figures and/or
light perception with bilateral buphthalmos eyes. The IOPs
for affected individuals in PKGL025 were either above the
normal range or was controlled by medical treatment (Table
1).
Initially, all reported loci for PCG were excluded for
linkage using closely spaced microsatellite markers (data not
shown). A genome wide scan was completed with the ABI
MD10  panel,  which  consisted  of  382  polymorphic
microsatellite markers and spaced at an average of 10 cM
across  the whole  genome.  During  the  genome-wide  scan,
LOD scores above 1.5 were obtained for markers D6S308,
D10S59,  D10S1652,  D11S1314,  D14S74,  D14S68,
D16S404, and D18S53 in PKGL005 and for markers D2S112,
D3S1279, D9S1776, D14S74, and D21S263 in PKGL025. Of
these  markers,  D6S308,  D10S59,  D10S1652,  D11S1314,
D16S404,  and  D18S53  have  closely  flanking  markers
yielding large negative LOD scores in PKGL005. Similarly,
in PKGL025, D2S112, D3S1279, D9S1776, and D21S263
have closely flanking markers yielding large negative LOD
scores.  Linkage  to  markers  other  than  chromosome  14q
markers that showed LOD scores greater than 1.5 during the
genome-wide  scan  was  further  excluded  by  haplotype
analysis of closely flanking markers.
Two point linkage analysis provided the first evidence of
linkage  to  markers  at  14q24.2–24.3  with  maximum  LOD
scores of 5.88 and 6.19 with markers D14S61 and D14S43 at
θ=0  for  families  PKGL005  and  PKGL025,  respectively.
Additional  STR  markers  selected  from  the  NCBI  and
Marshfield databases were genotyped to define the linkage
interval in these families. Two point LOD scores of 4.96, 5.60,
4.01, 4.84, 4.76, 5.88, 3.50, and 3.69 with D14S77, D14S43,
D14S284,  D14S1036,  D14S85,  D14S61,  D14S59,  and
D14S1008 at θ=0 were obtained for PKGL005 (Table 2).
Similarly, two point LOD scores 4.66, 6.19, 4.44, 5.28, 3.19,
and  5.38  with  D14S77,  D14S43,  D14S284,  D14S1036,
D14S85, and D14S74 at θ=0 were obtained for PKGL025
(Table 3).
Haplotype  analysis  supports  the  results  of  linkage
analysis  as  shown  in  Figure  1.  There  is  a  proximal
recombination  in  affected  individual  19  of  PKGL025  at
D14S63 and in affected individuals 28 and 41 of PKGL005 at
D14S289. Similarly, there is distal recombination in affected
individual  28  of  PKGL025  at  D14S606  and  in  affected
individual 41 of PKGL005 and unaffected individual 23 of
PKGL025 at D14S74 as well as in unaffected individual 14
of PKGL025 at D14S85. Taken together, these results suggest
TABLE 2. TWO POINT LOD SCORES OF PKGL005 WITH CHROMOSOME 14qMARKERS.
Marker cM Mb
Two-point LOD score values at recombination fraction(θ=)
Zmax θ max 0.00              0.01 0.03         0.05         0.07        0.09 0.10 0.20            0.30
D14S63 69.18 44.71 -5.50 -0.38 0.42 0.70 0.83 0.89 0.90 0.72 0.37 0.90 0.10
D14S258 76.28 50.65 -5.49 -0.38 0.41 0.69 0.83 0.89 0.89 0.72 0.37 0.89 0.09
D14S289 78.20 51.63 0.97 1.89 2.13 2.13 2.06 1.96 1.90 1.14 0.38 2.13 0.03
D14S77 80.82 53.63 4.96 4.84 4.61 4.38 4.15 3.91 3.80 2.62 1.51 4.96 0.00
D14S43 84.16 54.98 5.60 5.49 5.24 4.98 4.73 4.46 4.33 3.02 1.74 5.60 0.00
D14S284 84.69 55.75 4.01 3.89 3.65 3.42 3.18 2.94 2.82 1.72 0.84 4.01 0.00
D14S76 84.69 55.82 1.96 1.88 1.71 1.56 1.39 1.25 1.18 0.59 0.99 1.96 0.00
D14S1036 84.69 55.83 4.84 4.73 4.48 4.23 3.98 3.73 3.61 2.36 1.23 4.84 0.00
D14S85 84.76 – 4.76 4.65 4.40 4.15 3.90 3.65 3.52 2.29 1.17 4.76 0.00
D14S61 86.29 56.37 5.88 5.75 5.50 5.24 4.98 4.71 4.58 3.23 1.90 5.88 0.00
D14S59 87.36 58.11 3.50 3.40 3.20 2.99 2.79 2.59 2.49 1.53 0.75 3.50 0.00
D14S74 87.36 58.70 -0.06 2.95 3.18 3.16 3.06 2.93 2.70 1.96 1.06 3.18 0.03
D14S1008 89.19 59.94 3.69 3.61 3.43 3.24 3.06 2.88 2.79 1.90 1.10 3.69 0.00
D14S606 91.62 – -0.08 2.19 2.46 2.47 2.41 2.31 2.25 1.54 0.81 2.47 0.05
D14S974 93.76 – -2.14 0.25 0.60 0.70 0.72 0.71 0.70 0.46 0.21 0.72 0.07
LOD scores were calculated at different θ values for each marker with the FASTLINK version of MLINK from the LINKAGE
program package. Maximum LOD scores for each marker were calculated using ILINK.
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by markers D14S289 and D14S85. As marker D14S1036 is
uninformative for individual 10 of PKGL025 5, it is possible
that the distal boundary lies proximal to marker D14S1036.
Alleles  for  D14S77,  D14S43,  D14S284,  D14S76,  and
D14S1036 were homozygous for all affected individuals in
families  PKGL005  and  PKGL025  whereas  the  normal
individuals are either heterozygous carriers of the disease
allele or are homozygous for the normal allele.
The  critical  interval  on  chromosome  14q24.2–24.3
harbors coenzyme Q6 homolog (COQ6), which encodes a
flavin-dependent  monooxygenase  in  Saccharomyces
cerevisiae.  This  suggests  a  functional  similarity  with
CYP1B1. We investigated the COQ6 gene to identify the
mutation leading to the disease phenotype in these families by
sequencing all coding exons, exon-intron boundaries, and the
5'-untranslated region, but we did not find any pathogenic
mutations  in  this  gene.  Our  sequencing  results  identified
previously  reported  SNPs  rs3213692  and  rs2074930  in
PKGL005  and  rs17552038,  rs3213692,  and  rs7141392  in
PKGL025.
DISCUSSION
Here,  we  report  autosomal  recessive  primary  congenital
glaucoma  (PCG)  in  two  large  consanguineous  Pakistani
families, mapped to chromosome 14q24.2–24.3. Maximum
LOD  scores  of  5.88  and  6.19  with  markers  D14S61  and
D14S43  at  θ=0  for  families  PKGL005  and  PKGL025,
respectively,  the  lack  of  LOD  scores  above  2.0  for  any
markers other than chromosome 14q in the entire genome
scan, and the disease haplotype segregating with the disease
phenotype in both families strongly suggest that the PCG
locus maps to chromosome 14q24.2–24.3 in these families.
Haplotype analysis of these two families refines the disease
interval to a 6.56 cM (~4.2 Mb) region flanked by markers
D14S289 and D14S85. Localization of the disease interval to
14q24.2–24.3  in  two  consanguineous  Pakistani  families
strongly suggests genetic heterogeneity of primary congenital
glaucoma.
To  date,  three  PCG  loci  have  been  mapped  to
chromosomes 2p21 (GLC3A), 1p36 (GLC3B), and 14q24.3
(GLC3C) whereas mutations associated with PCG have only
been reported in the CYP1B1 gene [13-15,21]. Previously,
GLC3C was localized to chromosome 14q24.3 flanked by
markers D14S61 and D14S1000 as shown in Figure 2 [22]. In
 PKGL025,   individual   14   delineates   the   distal  boundary
at marker D14S85, strongly suggesting that the disease locus
in   PKGL025   does   not   overlap  with  GLC3C.  As  both
families in this study come from similar geographical and
racial  backgrounds,  haplotype  analysis  of  both  families
strongly suggests that the region flanked by markers D14S289
and D14S85 harbors the disease causing gene. However, we
cannot rule out the possibility that the disease phenotype in
these two families is caused by two different mutations, and
the   pathogenic   mutation   for  PKGL005   may  be   present
in a gene localized in a region overlapping with the GLC3C
locus.
The  critical  interval  on  chromosome  14q24.2–24.3
harbors 97 genes including coenzyme Q6 homolog (COQ6),
WD  repeat  domain  21A  (WDR21A),  and  ceh-10  homeo
TABLE 3. TWO POINT LOD SCORES OF PKGL025 WITH CHROMOSOME 14q MARKERS.
D14S63 69.18 44.71 -2.50 2.00 2.50 2.75 2.75 2.75 2.75 2.00 1.25 2.75 0.03
D14S258 76.28 50.65 2.50 4.00 4.25 4.25 4.00 4.00 3.75 2.75 1.50 4.25 0.03
D14S289 78.20 51.63 1.56 2.69 2.94 2.94 2.81 2.75 2.69 1.88 1.00 2.94 0.03
D14S77 80.82 53.63 4.66 4.59 4.44 4.28 4.09 3.91 3.81 2.78 1.69 4.66 0.00
D14S43 84.16 54.98 6.19 6.03 5.72 5.44 5.13 4.84 4.69 3.19 1.72 6.19 0.00
D14S284 84.69 55.75 4.44 4.31 4.06 3.81 3.63 3.38 3.25 2.06 1.06 4.44 0.00
D14S76 84.69 55.82 2.32 2.27 2.17 2.07 1.97 1.86 1.81 1.29 0.79 2.32 0.00
D14S1036 84.69 55.83 5.28 5.16 4.91 4.63 4.38 4.13 3.99 2.69 1.44 5.28 0.00
D14S85 84.69 – 3.19 3.13 3.06 2.94 2.81 2.68 2.62 1.81 1.06 3.19 0.00
D14S61 86.29 56.37 -4.34 1.91 2.22 2.25 2.22 2.16 2.09 1.47 0.78 2.25 0.05
D14S59 87.36 58.11 -4.34 5.75 5.75 5.75 5.50 5.50 5.25 4.00 2.50 5.75 0.01
D14S74 87.36 58.70 5.38 5.25 5.00 4.75 4.50 4.25 4.13 2.75 1.50 5.38 0.00
D14S1008 89.19 59.94 -4.34 2.75 3.50 3.75 3.50 3.50 3.50 2.50 1.50 3.75 0.05
D14S606 91.62 – -4.34 2.16 2.84 3.00 3.03 2.97 2.91 2.09 1.09 3.03 0.07
D14S974 93.76 – -4.34 1.50 2.19 2.38 2.44 2.44 2.38 1.75 0.94 2.44 0.07
LOD scores were calculated at different θ values for each marker with the FASTLINK version of MLINK from the LINKAGE
program package. Maximum LOD scores for each marker were calculated using ILINK.
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Marker cM Mb
Two-point LOD score values at recombination fraction(θ=)
Zmax θ max 0.00           0.01         0.03         0.05         0.07        0.09 0.10 0.20         0.30Figure 1. Pedigree of families PKGL005 and PKGL025. Squares denote males, circles indicate females, filled symbols represent affected
individuals, double lines between individuals indicate consanguinity, and a diagonal line through a symbol signify that the family member is
deceased. The haplotypes of 15 adjacent chromosome 14q14.2–24.3 microsatellite markers for families PKGL005 (A) and family PKGL025
(B) are shown with alleles forming the risk haplotype shaded black, alleles cosegregating with primary congenital glaucoma (PCG) but not
showing homozygosity shaded gray, and alleles not cosegregating with PCG shown in white.
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1663domain  containing  homolog  (CHX10).  COQ6  is  a  lipid
soluble  antioxidant  and  an  obligatory  component  of  the
respiratory chain and uncoupling proteins [23,24]. COQ6 in
Saccharomyces  cerevisiae  encodes  a  flavin-dependent
monooxygenase,  suggesting  a  functional  similarity  with
CYP1B1, a mixed-function monooxygenase that belongs to
the cytochrome P450 1B subfamily [25]. We sequenced all
the coding exons and exon-intron boundaries as well as the 5’
and 3’ regions of affected individuals of families PKGL005
and PKGL025; however we did not identify any pathogenic
mutation.
WDR21A  belongs  to  the  WD  repeat  protein  family.
Members of this family are involved in a variety of cellular
processes  including  cell  cycle  progression,  signal
transduction, apoptosis, and gene regulation. Mutations in
WDR36, also a member of the WD repeat protein family, have
been  associated  with  adult-onset  primary  open-angle
glaucoma (POAG) [26]. In contrast, CHX10 is homeobox
transcription factor gene that is expressed in progenitor cells
of the developing neuroretina and in the inner nuclear layer of
Figure  2.  Schematic  representation  of  linkage  on  chromosome
14q24.2–24.3 in families PKGL005 and PKGL025. Filled circles
denote  STR  markers,  and  solid  vertical  lines  represent  the
chromosomal  intervals  in  which  markers  are  homozygous  for
affected members of each of the two families.
the mature retina. In humans, CHX10 mutations are associated
with microphthalmia with cataracts and iris abnormalities,
isolated  microphthalmia  with  coloboma  3,  isolated
microphthalmia 2, and isolated microphthalmia with cloudy
corneas  [27-29].  Similarly,  mutations  in  CHX10  cause
microphthalmia, progressive degeneration of the retina, and
an absence of the optic nerve in mice [30]. We are currently
sequencing  these  two  candidate  genes  to  identify  any
pathogenic mutations.
In summary, we have localized autosomal recessive PCG
to  chromosome  14q24.2–24.3  in  two  consanguineous
Pakistani families. Identification of the PCG causing gene at
this  locus  will  help  to  unveil  the  underlying  molecular
complexity of primary congenital glaucoma and will be a
valuable  addition  to  the  existing  repertoire  of  glaucoma
genetics, particularly of PCG. Finally, it will be helpful in
screening for carrier status and genetic counseling of PCG
families  especially  in  the  Pakistani  population  to  prevent
severe visual impairment and blindness.
ACKNOWLEDGMENTS
The authors are grateful to members of both families for their
participation in this study. We sincerely thank the staff of the
Layton Rehmatullah Benevolent Trust (LRBT) hospital for
their  help  in  the  clinical  evaluations  of  the  affected
individuals. This work was supported by the Higher Education
Commission (Islamabad, Pakistan), the Ministry of Science
and  Technology  (Islamabad,  Pakistan),  and  the
COMSTECH.EMRO  project  of  the  World  Health
Organization (Registration No: RAB and GH 06–07_24).
REFERENCES
1. Sarfarazi  M.  Recent  advances  in  molecular  genetics  of
glaucomas.  Hum  Mol  Genet  1997;  6:1667-77.  [PMID:
9300658]
2. Vasiliou V, Gonzalez FJ. Role of CYP1B1 in Glaucoma. Annu
Rev Pharmacol Toxicol 2008; 48:333-58. [PMID: 17914928]
3. Ho CL, Walton DS. Primary congenital glaucoma: 2004 update.
J Pediatr Ophthalmol Strabismus 2004; 41:271-88. [PMID:
15478740]
4. Wiggs JL, Auguste J, Allingham RR, Flor JD, Pericak-Vance
MA, Rogers K, LaRocque KR, Graham FL, Broomer B, Del
Bono  E,  Haines  JL,  Hauser  M.  Lack  of  association  of
mutations in optineurin with disease in patients with adult-
onset primary open-angle glaucoma. Arch Ophthalmol 2003;
121:1181-3. [PMID: 12912697]
5. Reddy  ABM,  Panicker  SG,  Mandal  AK,  Hasnain  SE,
Balasubramanian  D.  Identification  of  R368H  as  a
predominant  CYP1B1  allele  causing  primary  congenital
glaucoma in Indian patients. Invest Ophthalmol Vis Sci 2003;
44:4200-3. [PMID: 14507861]
6. Allen  L,  Burian  HM,  Braley  AE.  A  new  concept  of  the
development of the anterior chamber angle; its relationship to
developmental  glaucoma  and  other  structural  anomalies.
AMA Arch Ophthalmol 1955; 53:783-98. [PMID: 14375435]
Molecular Vision 2008; 14:1659-1665 <http://www.molvis.org/molvis/v14/a196> © 2008 Molecular Vision
16647. Maumenee AE. The pathogenesis of congenital glaucoma: a
new theory. Trans Am Ophthalmol Soc 1958; 56:507-70.
[PMID: 13647611]
8. Kupfer C, Kaiser-Kupfer MI. Observations on the development
of  the  anterior  chamber  angle  with  reference  to  the
pathogenesis  of  congenital  glaucomas.  Am  J  Ophthalmol
1979; 88:424-6. [PMID: 484670]
9. Anderson DR. The development of the trabecular meshwork
and its abnormality in primary infantile glaucoma. Trans Am
Ophthalmol Soc 1981; 79:458-85. [PMID: 7342408]
10. Francois  J.  Congenital  glaucoma  and  its  inheritance.
Ophthalmologica 1980; 181:61-73. [PMID: 7219964]
11. Gencik A. Epidemiology and genetics of primary congenital
glaucoma  in  Slovakia.  Description  of  a  form  of  primary
congenital  glaucoma  in  gypsies  with  autosomal-recessive
inheritance and complete penetrance. Dev Ophthalmol 1989;
16:76-115. [PMID: 2676634]
12. Turacli ME, Aktan SG, Sayli BS, Akarsu N. Therapeutical and
genetical aspects of congenital glaucomas. Int Ophthalmol
1992; 16:359-62. [PMID: 1428571]
13. Stoilov I, Akarsu AN, Alozie I, Child A, Barsoum-Homsy M,
Turacli ME, Or M, Lewis RA, Ozdemir N, Brice G, Aktan
SG,  Coca-Prados  M,  Sarfarazi  M.  Sequence  analysis  and
homology  modeling  suggest  that  primary  congenital
glaucoma on 2p21 results from mutations disrupting either
the  hinge  region  or  the  conserved  core  structures  of
cytochrome P4501B1. Am J Hum Genet 1998; 62:573-84.
[PMID: 9497261]
14. Stoilov  I,  Akarsu  AN,  Sarfarazi  M.  Identification  of  three
different  truncating  mutations  in  cytochrome  P4501B1
(CYP1B1)  as  the  principal  cause  of  primary  congenital
glaucoma (Buphthalmos) in families linked to the GLC3A
locus  on  chromosome  2p21.  Hum  Mol  Genet  1997;
6:641-7. [PMID: 9097971]
15. Akarsu  AN,  Turacli  ME,  Aktan  SG,  Barsoum-Homsy  M,
Chevrette L, Sayli BS, Sarfarazi M. A second locus (GLC3B)
for primary congenital glaucoma (Buphthalmos) maps to the
1p36 region. Hum Mol Genet 1996; 5:1199-203. [PMID:
8842741]
16. Simha  N,  Verin  P,  Gauthier  L.  Congenital  glaucoma  of
dominant  autosomal  transmission  apropos  of  a  family.
Management.  Bull  Soc  Ophtalmol  Fr  1989;  89:1149-51.
[PMID: 2620399]
17. Kaur K, Reddy ABM, Mukhopadhyay A, Mandal AK, Hasnain
SE, Ray K, Thomas R, Balasubramanian D, Chakrabarti S.
Myocilin gene implicated in primary congenital glaucoma.
Clin Genet 2005; 67:335-40. [PMID: 15733270]
18. Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A,
Eisenberg A. A simple and efficient non-organic procedure
for the isolation of genomic DNA from blood. Nucleic Acids
Res 1989; 17:8390. [PMID: 2813076]
19. Lathrop GM, Lalouel JM. Easy calculations of lod scores and
genetic risks on small computers509. Am J Hum Genet 1984;
36:460-5. [PMID: 6585139]
20. Schaffer AA, Gupta SK, Shriram K, Cottingham RW. Avoiding
recomputation in genetic linkage analysis 1669. Hum Hered
1994; 44:225-37. [PMID: 8056435]
21. Sarfarazi M, Akarsu AN, Hossain A, Turacli ME, Aktan SG,
Barsoum-Homsy M, Chevrette L, Sayli BS. Assignment of a
locus  (GLC3A)  for  primary  congenital  glaucoma
(Buphthalmos)  to  2p21  and  evidence  for  genetic
heterogeneity. Genomics 1995; 30:171-7. [PMID: 8586416]
22. Stoilov IR, Sarfarazi M. The third genetic locus (GLC3C) for
primary congenital glaucoma (PCG) maps to chromosome
14q24.3.  ARVO  Annual  Meeting;  2002  May  5-10;  Fort
Lauderdale (FL)
23. Bentinger M, Brismar K, Dallner G. The antioxidant role of
coenzyme.  Mitochondrion  2007;  7:S41-50.  [PMID:
17482888]
24. Fernández-Ayala  DJ,  Lopez-Lluch  G,  Garcia-Valdes  M,
Arroyo  A,  Navas  P.  Specificity  of  coenzyme  Q10  for  a
balanced  function  of  respiratory  chain  and  endogenous
ubiquinone biosynthesis in human cells. Biochim Biophys
Acta 2005; 1706:174-83. [PMID: 15620378]
25. Gin P, Hsu AY, Rothman SC, Jonassen T, Lee PT, Tzagoloff
A, Clarke CF. The Saccharomyces cerevisiae COQ6 gene
encodes a mitochondrial flavin-dependent monooxygenase
required for coenzyme Q biosynthesis. J Biol Chem 2003;
278:25308-16. [PMID: 12721307]
26. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E,
Liebmann J, Ritch R, Heon E, Crick RP, Child A, Sarfarazi
M. Identification of a novel adult-onset primary open-angle
glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005;
14:725-33. [PMID: 15677485]
27. Bar-Yosef U, Abuelaish I, Harel T, Hendler N, Ofir R, Birk O.
CHX10  mutations  cause  non-syndromic  microphthalmia/
anophthalmia in Arab and Jewish kindreds. Hum Genet 2004;
115:302-9. [PMID: 15257456]
28. Faiyaz-Ul-Haque M, Zaidi SH, Al-Mureikhi MS, Peltekova I,
Tsui LC, Teebi AS. Mutations in the CHX10 gene in non-
syndromic  microphthalmia/anophthalmia  patients  from
Qatar. Clin Genet 2007; 72:164-6. [PMID: 17661825]
29. Percin E, Ploder LA, Yu JJ, Arici K, Horsford DJ, Rutherford
A,  Bapat  B,  Cox  DW,  Duncan  AM,  Kalnins  VI,  Kocak-
Altintas A, Sowden JC, Traboulsi E, Sarfarazi M, McInnes
RR. Human microphthalmia associated with mutations in the
retinal  homeobox  gene  CHX10.  Nat  Genet  2000;
25:397-401. [PMID: 10932181]
30. McInnes RR, Basu S, Novak J, Ploder L, Liang MY, Hawes N,
Taylor B, Roderick T, Goldman D, Hankin M, Burmeister M.
The ocular retardation (ocJ) mouse has an ochre mutation in
the homeobox gene Chx10: direct evidence for Chx10 as a
major determinant of retinal development. Am J Hum Genet
1994; 55:A3.
Molecular Vision 2008; 14:1659-1665 <http://www.molvis.org/molvis/v14/a196> © 2008 Molecular Vision
The print version of this article was created on 1 September 2008. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
1665